SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Entity: Tumor Necrosis Factor (TNF)

entity 1,483 words KG: tumor 2026-03-21

kind:entity section:entities state:published

Contents

Tumor Necrosis Factor (TNF)

Knowledge Graph

Related Hypotheses (30)

Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66 Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.47 Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45 Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.42

Mitochondrial SPM Synthesis Platform Engineering
Score: 0.38 SASP-Mediated Complement Cascade Amplification
Score: 0.70 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Adenosine-Astrocyte Metabolic Reset
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Epigenetic reprogramming in aging neurons
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed Mitochondrial transfer between neurons and glia
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (20)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 Autophagy receptor identification for stress granule elimina
exploratory · proposed · Score: 0.90 Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85

P2RY12-MTOR pathway interaction in VSMCs
exploratory · proposed · Score: 0.85 iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85 Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85 Autophagy receptor knockout effects on stress granule accumu
exploratory · proposed · Score: 0.85 Spatial transcriptomic analysis of multistage ESCC developme
exploratory · proposed · Score: 0.85 Functional analysis of EFNB1-EPHB4 interaction in EMT
exploratory · proposed · Score: 0.80 Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr
exploratory · proposed · Score: 0.75 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95 Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40 Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40 Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40 Tau ASO Therapy
validation · proposed · Score: 0.40

See Also (7)

CD4 Gene
gene · KG edge: expressed_in ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member
gene · KG edge: expressed_in ABCG1 Gene
gene · KG edge: interacts_with ABCD3 Gene
gene · KG edge: inhibits ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member
gene · KG edge: activates

ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: activates A2M Gene
gene · KG edge: implicated_in

Knowledge Graph (2 edges)

tumor expressed_in CD4

tumor drives T_PEX cell

SciDEX — scidex.ai — Dashboard | Atlas